Reynaldo Lopez
Internal Medicine · Miami Gardens, FLNPI 1215264536
Payments from drug & device makers
Across 52 payments — averaging $19,069 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Evofem Biosciences, Inc.$604K
- Eli Lilly$268K
- Novartis$119K
- Astrazeneca UK Limited$475
- AbbVie$152
- Intuitive Surgical$60
- plus $37 from 1 others
Across 2 payments — averaging $13,858 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$28K
What the payments were for
- Consulting fees$47583%
- Food & beverage$9717%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Evofem Biosciences, Inc. | 34 | $604,143 |
| Eli Lilly | 6 | $267,707 |
| Novartis | 7 | $119,024 |
| Astrazeneca UK Limited | 1 | $475 |
| AbbVie | 1 | $152 |
| Intuitive Surgical | 1 | $60 |
| Johnson & Johnson | 2 | $37 |
How this compares
$991,598 in reported general payments places this provider in the 95th percentile of 8,530 internal medicine providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 29 | $19,032 |
| JardianceEmpagliflozin | 17 | $10,033 |
| Fenofibrate | 41 | $8,012 |
| Insulin Aspart Prot Mix 70-30Insulin Aspart Prot/Insuln Asp | 46 | $7,900 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 45 | $3,555 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 99 | $3,323 |
| Atorvastatin Calcium | 457 | $2,920 |
| Gabapentin | 155 | $2,841 |
| Nifedipine ErNifedipine | 62 | $2,511 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 23 | $2,457 |
| Dabigatran EtexilateDabigatran Etexilate Mesylate | 14 | $2,294 |
| Alphagan PBrimonidine Tartrate | 12 | $2,170 |
| SynthroidLevothyroxine Sodium | 18 | $1,988 |
| Levothyroxine Sodium | 140 | $1,759 |
| Losartan Potassium | 285 | $1,580 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieAlphagan P, Synthroid | $152 | $4,15830 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 8,530 internal medicine providers in Florida.
Other internal medicine in Miami Gardens
- Yaneicy Gonzalez RojasCoral Gables$93.5M
- Juan Carlos RondonHollywood$66.8M
- Jaynier MoyaPembroke Pines$45.4M
- Mark KutnerMiami$35.7M
- Gilberto JimenezHialeah$35.6M
- Mira BaronWest Palm Beach$29.6M
- William SanchezHialeah$28.9M
- Nelia Sanchez-CrespoHollywood$28.8M
- Kwabena AyesuOrlando$27.6M
- Michael DeverWindermere$24M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.